Evidence map›Paper›PMID 19705119›Full record

ArticleRheumatology international2010

Autoantibodies in silicosis patients and in silica-exposed individuals.

Gabriel Zaghi, Fábio Koga, Renato M Nisihara, Thelma L Skare, Antonieta Handar, Shirley R Rosa Utiyama, Marilia Barreto Silva

Abstract read
PubMed Publisher
In one paragraph

Article in Rheumatology international, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
0.5field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Erasmus Syndrome: A Case Report and Literature Review.The American journal of case reports · 2022
    Review
  3. Article
  4. Review
  5. Article
  6. Erasmus Syndrome in a 42-Year-Old Male: A Rare Case Report.Journal of clinical and diagnostic research : JCDR · 2015
    Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Gabriel ZaghiRheumatology Unit, Curitiba's Evangelic University Hospital, Rua João Alencar Guimarães, 796, Curitiba, PR, 80310420, Brazil.
Fábio Koga
Renato M Nisihara
Thelma L Skare
Antonieta Handar
Shirley R Rosa Utiyama
Marilia Barreto Silva
Hospital Universitário Evangélico de Curitiba · BRHospital de Clínicas Universidade Federal do Paraná · BRUniversidade Federal do Paraná · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of this study was to evaluate the prevalence of autoantibodies in silica-exposed patients with and without silicosis and without any known rheumatic disease. We studied 61 males exposed to silica for a mean time of 12.2 +/- 10.2 years of exposure. A total of 72.1% (44/61) of them presented with pulmonary silicosis. As control group we included 62 healthy males. In all samples we screened for rheumatoid factor (latex agglutination), antinuclear antibodies (indirect immunofluorescence), anti Scl-70 (ELISA) and ANCA (indirect immunofluorescence technique). One patient (1.6%) of the silica group had weakly positive ANA (titer 1:80, centromeric pattern); one (1.6%) had atypical ANCA and seven patients (11.4%) presented positive rheumatoid factor (values range from 8 to 32 UI/ml). One control patient had a positive RF and none of them had positive ANA or ANCA. All patients and controls were negative for anti-Scl-70. The finding of positive RF was higher in the silica-exposed patients (p = 0.032; Fisher). All patients with positive RF had pulmonary silicosis. In the silica-exposed group we could not find a relationship between the presence of RF and age (p = 0.21; Mann-Whitney), smoking habits (p = 0.25; Fisher) but a positive relationship was found with exposure time to silica dust (p = 0.005; Mann-Whitney). We conclude that there was 11.4% prevalence of low titer RF in the silica-exposed patients without known rheumatic disease. RF was more common in patients with longer exposure to silica dust and appeared only in those with silicosis. The presence of ANA, Scl-70 and ANCA was the same as in the control population.

Indexed as

AdultAntibodies, Antineutrophil CytoplasmicAntibodies, AntinuclearAutoantibodiesComorbidityEnvironmental ExposureHep G2 CellsHumansMaleMiddle AgedPrevalenceRheumatic DiseasesRheumatoid FactorSilicon DioxideSilicosisAntibodies, Antineutrophil CytoplasmicAntibodies, AntinuclearAutoantibodiesRheumatoid FactorSilicon Dioxide

Identifiers

PMID19705119
OpenAlexW1985722893

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.